SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune Inc is currently trending due to intense community speculation surrounding an imminent strategic partnership or buyout for its Pemvidutide asset, which is seen as a potential leader in the MASH and obesity markets. This bullish sentiment is strongly supported by technical indicators pointing to a potential short squeeze and observed institutional interest, leading many investors to anticipate a substantial re-evaluation of the company's valuation.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as CEO Ryan Cohen has significantly increased his stake, publicly challenging other CEOs to demonstrate similar conviction by buying shares with their own money. This substantial insider activity has ignited widespread community excitement, driving speculation about a potential short squeeze and rallying cries like "shorts are f****d." The renewed focus on insider alignment and the re-emergence of the meme stock narrative are fueling intense discussion.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending as it formally submitted the first consolidated deep-sea mining application under NOAA's new expedited permitting framework, significantly expanding its proposed commercial recovery area. The community is actively discussing how this, combined with a crucial Congressional hearing on seabed metals for national security, substantially derisks the project and signals potential government backing for critical mineral independence.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending intensely as the market eagerly awaits its upcoming earnings report, with community speculation heavily focused on potential updates regarding its foundry business, AI demand, and possible strategic partnerships. While many anticipate a significant upward move based on a perceived turnaround and strong sector tailwinds, others warn of profit-taking given the substantial rally leading into the announcement, creating palpable tension across the trading community.

GitLab, Inc. engages in the intelligent DevSecOps platform for software innovation. The firm enables organizations to increase developer productivity, improve operational efficiency, reduce security and compliance risk, and accelerate digital transformation. The company was founded by Dmitriy Zaporozhets and Sid Sijbrandij in 2011 and is headquartered in San Francisco, CA.

Gitlab Inc - Ordinary Shares - Class A

Gitlab Inc

GitLab is generating intense conversation following a significant stock plunge despite its earnings exceeding expectations, fueling widespread speculation about an imminent acquisition at a premium. The community is sharply divided, with many anticipating a rebound from current "oversold" levels, while others highlight persistent valuation concerns and broader software sector headwinds.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Holdings Inc

Ondas Holdings is a focal point of discussion as traders grapple with perceived selling pressure from a recent capital raise, despite an influx of bullish analyst upgrades and promising prospects within the rapidly expanding drone and counter-UAS sector. The community is actively debating market manipulation and comparing ONDS's volatile performance to peers, while many long-term investors anticipate significant contract awards and a strong rebound for the stock.

Ascent Solar Technologies, Inc. engages in the design, development, and manufacture of solar technology and power solutions for remote locations and extreme environments. It integrates photovoltaic modules into a variety of applications such as aerospace, defense, transportation, and electronic products. The company was founded by Mohan S. Misra and Joseph H. Armstrong on October 18, 2005 and is headquartered in Thornton, CO.

Ascent Solar Technologies Inc

Ascent Solar Technologies (ASTI) is trending amidst heightened enthusiasm for space infrastructure, specifically driven by recent discussions around solar-powered AI satellites. The community is buzzing about ASTI's unique lightweight, flexible thin-film solar technology, positioning it as a key player for next-generation satellite constellations and defense initiatives. Speculation of significant contract announcements and a potential short squeeze are fueling strong bullish sentiment, despite historical volatility.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is trending as gold surges to new all-time highs, boosted by an upgraded price target from Goldman Sachs and widespread discussions about its role as a safe haven. While many investors celebrate short squeezes and gold's resilience amidst global uncertainties, a significant segment of the community warns of a speculative 'mania' and anticipates a sharp pullback.

60 Degrees Pharmaceuticals, Inc. develops medicines for the treatment and prevention of infectious diseases. Its product Arakoda helps in the prevention of malaria. The company was founded by Geoffrey Dow on September 9, 2010 and is headquartered in Washington, DC.

60 Degrees Pharmaceuticals Inc

SXTP is trending following news of its partnership with Runway Health, aiming to broaden telehealth access for its malaria prevention drug, ARAKODA, which has ignited a significant price surge. The community is sharply divided, with bulls celebrating substantial gains and anticipating further upside due to the low float, while skeptics caution about a potential 'pump and dump' and impending dilution.

Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Rockville, MD.

Sensei Biotherapeutics Inc

Sensei Biotherapeutics (SNSE) is experiencing a surge in attention due to its extremely low share float and high short interest, fueling intense community speculation for a significant short squeeze. Traders are actively comparing it to other recent microcap parabolic runners, anticipating substantial price increases as the company explores strategic alternatives.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Meitav Investment House Ltd. Lowers Stock Holdings in InMode Ltd. $INMD

Meitav Investment House Ltd. cut its stake in shares of InMode Ltd. (NASDAQ:INMD - Free Report) by 26.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities...

<ul class="summary-bullets"><li>The firm is scheduled to report its financial performance for Q4 and fiscal 2025 ahead of the market open on Tuesday, Feb. 10, 2026.</li><li>The company’s total revenue for fiscal 2025 is projected around $370.2 million to $370.4 million.</li><li>Looking ahead, the company has set a revenue forecast for fiscal 2026 between $365 million and $375 million.</li></ul><p>InMode (INMD) stock is gaining investor attention in Friday’s premarket after the medical technology provider announced its fourth quarter (Q4) sales outlook.</p><p>The company said it anticipated its fourth-quarter (Q4) sales to fall within a tight range of $103.6 million to $103.8 million, compared with the analyst consensus estimate of $104.64 million, according to FiscalAI data.&nbsp;</p><h2 class="st-heading-2">2025 And 2026 Outlook&nbsp;</h2><p>The firm is scheduled to report its financial performance for Q4 and fiscal 2025 ahead of the market open on Tuesday, Feb. 10, 2026. The company’s total revenue for fiscal 2025 is projected to be around $370.2 million to $370.4 million, below the analysts' consensus estimate of $371 million, as per FiscalAI data.</p><p>InMode expects a non-GAAP gross margin near the high end of the 70% range for the full 2025 fiscal year.&nbsp;Looking ahead, the company has set a revenue forecast for fiscal 2026 between approximately $365 million and $375 million.&nbsp;<a href="https://stocktwits.com/symbol/INMD">InMode stock</a> inched 0.8% higher in Friday’s premarket.&nbsp;</p><h2 class="st-heading-2">What Are Stocktwits Users Saying?&nbsp;</h2><p>On Stocktwits, retail sentiment around the stock remained in ‘bullish’ territory while message volume shifted to ‘high’ from ‘normal’ levels in 24 hours.&nbsp;</p><figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_01_09_055125_png_79a97af5f3.webp" alt="INMD’s Sentiment Meter and Message Volume as of 05:45 a.m. ET on Jan. 9, 2026 | Source: Stocktwits" width="926" height="105"></figure><p>A bullish Stocktwits user highlighted sequential growth and high margins.&nbsp;</p><p><stembedurl>https://stocktwits.com/thinkandpick/message/641307067</stembedurl></p><p>Another user pointed to ongoing pressure in the aesthetic device sector, noting that demand remains subdued, but added that the latest outlook broadly aligns with the company’s earlier outlook for 2025, suggesting performance is tracking as expected.</p><p><stembedurl>https://stocktwits.com/findingthestock/message/641285697</stembedurl></p><h2 class="st-heading-2">Brokerage Radar&nbsp;</h2><p>In December, Canaccord cut its price target on InMode to $15 from $16 and kept a ‘Hold’ rating on the stock, according to TheFly. The firm said it still has a positive long-term view on the medical technology industry going into 2026, noting that mid-sized company valuations remain low, and deal activity is increasing.</p><p>INMD stock has declined by over 10% in the last 12 months.&nbsp;</p><p>Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-big-oil-invest-at-least-100-billion-venezuela/cmU29w3R4d2">Trump Says Big Oil Will Invest At Least $100 Billion To Rebuild Venezuela's Oil Infrastructure</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

 A worker produces medical instrument at Shandong Yixing Medical Instrument Co., Ltd.

INMD Stock Draws Investor Attention On Q4 Financial Update

The company said it anticipated its fourth-quarter (Q4) sales to fall within a tight range of $103.6 million to $103.8 million, compared with the analyst consensus estimate of $104.64 million, according to FiscalAI data. 

Equity

The company said it anticipated its fourth-quarter (Q4) sales to fall within a tight range of $103.6 million to $103.8 million, compared with the analyst consensus estimate of $104.64 million, according to FiscalAI data. 


InMode (NASDAQ:INMD) Trading Down 8.4% - What's Next?

InMode (NASDAQ:INMD) Trading Down 8.4% - What's Next...

InMode Ltd. (NASDAQ:INMD) Given Consensus Rating of "Hold" by Brokerages

Shares of InMode Ltd. (NASDAQ:INMD - Get Free Report) have earned an average recommendation of "Hold" from the ten research firms that are presently covering the company, Marketbeat Ratings reports...

InMode (NASDAQ:INMD) Shares Pass Above 200 Day Moving Average - Should You Sell?

InMode (NASDAQ:INMD) Share Price Crosses Above 200 Day Moving Average - What's Next...

Lind Value II ApS Reduces Stake in InMode Ltd. $INMD

Lind Value II ApS trimmed its holdings in InMode Ltd. (NASDAQ:INMD - Free Report) by 35.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities...

Squarepoint Ops LLC Has $2.08 Million Stake in InMode Ltd. $INMD

Squarepoint Ops LLC increased its stake in InMode Ltd. (NASDAQ:INMD - Free Report) by 92.9% in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 143,758...

InMode Ltd. (NASDAQ:INMD) Receives Average Rating of "Hold" from Analysts

InMode Ltd. (NASDAQ:INMD - Get Free Report) has been assigned an average rating of "Hold" from the ten ratings firms that are currently covering the company, MarketBeat reports. One analyst has rated...

JPMorgan Chase & Co. Lowers Position in InMode Ltd. $INMD

JPMorgan Chase & Co. decreased its position in shares of InMode Ltd. (NASDAQ:INMD - Free Report) by 40.2% during the second quarter, according to its most recent filing with the SEC. The firm owned...

Divisadero Street Capital Management LP Makes New $1.40 Million Investment in InMode Ltd. $INMD

Divisadero Street Capital Management LP bought a new position in shares of InMode Ltd. (NASDAQ:INMD - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing...

InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. It also designs, develops, manufactures and markets non-invasive medical aesthetic products that target a array of procedures including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture and superficial benign vascular and pigmented lesions. The company was founded by Moshe Mizrahy and Michael Kreindel on January 2, 2008 and is headquartered in Yokneam, Israel.

Inmode Ltd

Up 10% or more

0% to up 9%

Down 1% to 9%

Down 10% or more

The S&P 500 enters 2026 after a strong run. What kind of return do you expect this year?

How will the S&amp;P 500 perform in 2026?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	$0.42	--	--	N/A
Q3 '25	$0.35	$0.38	7.05%	BEAT
Q2 '25	$0.41	$0.47	14.34%	BEAT
Q1 '25	$0.35	$0.31	-12.32%	MISSED
Q4 '24	$0.53	$0.42	-20.42%	MISSED

INMD
Inmode Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest INMD News

INMDInmode Ltd